Incresync

Incresync 25/15 – Complete Drug Overview (Alogliptin 25 mg + Pioglitazone 15 mg)

What is Incresync 25/15?

Incresync 25/15 is a combination oral medication used to manage type 2 diabetes mellitus. It contains two active ingredients:

 • Alogliptin 25 mg – a DPP-4 inhibitor that enhances incretin levels, boosting insulin secretion and reducing glucagon production after meals.

 • Pioglitazone 15 mg – a thiazolidinedione that improves insulin sensitivity in muscle and liver tissues, helping lower blood glucose.

Indications:

 • Used to improve glycemic control in adults with type 2 diabetes, especially when:

 • Diet and exercise alone are insufficient.

 • Single-agent therapy is no longer effective.

 • Suitable as a dual therapy for patients needing a simplified treatment regimen.

Warnings and Precautions:

 • Not indicated for type 1 diabetes or diabetic ketoacidosis.

 • Use with caution in patients with heart failure or hepatic impairment.

 • May cause weight gain or fluid retention.

Dosage and Administration:

 • One tablet taken once daily, with or without food.

 • It’s recommended to take it at the same time each day for consistent blood sugar control.

Incresync 25/30 – Complete Drug Overview (Alogliptin 25 mg + Pioglitazone 30 mg)

What is Incresync 25/30?

Incresync 25/30 is a higher-dose version of the same dual-action therapy, designed for patients requiring stronger control of blood sugar. It contains:

 • Alogliptin 25 mg

 • Pioglitazone 30 mg

This formulation is ideal for patients whose diabetes is not adequately managed on lower doses.

Indications:

 • Helps manage chronic hyperglycemia in adults with type 2 diabetes.

 • Suitable as monotherapy or in combination with other antidiabetic medications.

 • Especially useful in patients with insulin resistance requiring higher Pioglitazone dosage.

Warnings and Side Effects:

 • Similar to the 25/15 version, but with a higher risk of weight gain and fluid retention due to the increased Pioglitazone content.

 • Regular liver function and heart monitoring is advised.

Dosage and Administration:

 • One tablet daily, taken orally. Dose adjustments may be necessary based on blood glucose monitoring and patient response.